APVO · Aptevo Therapeutics Inc
United States · RS rating 12 · As of 2026-10-14
| Price | 1.73 USD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 12 / 77 / 3 / 3 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 16 / 27 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +17.2% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +94.1% |
| Market cap (USD) | $5.8M |